Apathy: A Complex Symptom Specific to the Clinical Pattern of Presentation of Parkinson's Disease?

American Journal of Alzheimer's Disease & Other Dementias®

Volumn 27, Issue 3, 2012, Pages 196-201

  Moretti, Rita ^a   Torre, Paola ^a   Antonello, Rodolfo M ^a   Rosin, Marta Vidus ^a   Esposito, Francesca ^a   Furman, Matej Rubelli ^a   Bellini, Giuseppe ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

Author keywords

akinetic PD; apathy; behavior; tremor

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT;

AGED; APATHY; ARTICLE; DEPRESSION; FEMALE; HUMAN; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PARKINSON DISEASE; PATHOPHYSIOLOGY; PREVALENCE; PSYCHOLOGICAL ASPECT;

AGED; APATHY; DEPRESSION; DOPAMINE AGONISTS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; PREVALENCE;

EID: 84865433077     PISSN: 15333175     EISSN: 19382731     Source Type: Journal    
DOI: 10.1177/1533317512445502     Document Type: Article

References (41)

1. The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
2. The authors received no financial support for the research, authorship, and/or publication of this article.
3. Pedersen KF Larsen JP Alves G Aarsland D. Prevalence and clinical correlates of apathy in Parkinson-s disease: a community-based study. Parkinsonism Relat Disord. 2009; 15(4):295-299.
4. Isella V Melzi P Grimaldi M, et al Clinical, neuropsychological and morphometric correlates of apathy in Parkinson-s disease. Mov Disord. 2002; 17(2):366-371.
5. Ringman JM Diaz-Olavarrieta C Rodriguez Y Fairbanks L Cummings J.L., The prevalence and correlates of neuropsychiatric symptoms in a population with Parkinson-s disease in Mexico. Neuropsychiatry Neuropsychol Behav Neurol. 2002; 15(2):99-105.
6. Starkstein SE Mayberg SE Preziosi TJ, et al Reliability, validity and clinical correlates of apathy in Parkinson-s disease. J Neuropsychiatry. 1992; 4(2):134-139.
7. Pluck GC Brown RG. Apathy in Parkinson-s disease. J Neurol Neurosurg Psychiatry. 2002; 73(6):636-642.
8. Dujardin K Sockeel P Devos D, et al Characteristics of apathy in Parkinson-s disease. Mov Disord. 2007; 22(6):778-784.
9. Starkstein SE Leentjens AF. The nosological position of apathy in clinical practice. J Neurol Neurosurg Psychiatry. 2008; 79(10):1088-1092.
10. Brown RG Pluck G. Negative symptoms: the “pathology” of motivation and goal-directed behaviour. Trends Neurosci. 2000; 23(9):412-417.
11. Levy R Dubois B. Apathy and the functional anatomy of the prefrontal cortex--basal ganglia circuits. Cerebral Cortex. 2006; 16(7):916-928.
12. Aarsland D Cummings JL Larsen JP. Neuropsychiatric differences between Parkinson-s disease with dementia and Alzheimer-s disease. Int J Geriatr Psychiatry. 2001; 16(2):184-191.
13. Aarsland D Litvan I Larsen JP. Neuropsychiatric symptoms of patients with progressive supranuclear palsy and Parkinson-s disease. J Neuropsychiatry Clin Neurosci. 2001; 13(1):42-49.
14. Stuss DT Van Reekum R Murphy KJ. Differentiation of states and causes of apathy. In: Borod JC, ed The Neuropsychology of Emotion. Oxford: Oxford University Press; 2000: 340-363.
15. Hughes AJ Daniel SE Kilford L Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson-s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992; 55(3):181-184.
16. Abdo WF van de Warrenburg BPC Burn DJ Quinn NP Bloem BR. The clinical approach to movement disorders. Nat Rev Neurol. 2010; 6(1):29-37.
17. Rajput AH Voll A Rajput ML Robinson CA Rajput A. Course in Parkinson disease subtypes: a 39-year clinicopathologic study. Neurology. 2009; 73(3):206-212.
18. Briggs G Nebes R. Patterns of hand preference in a student population. Cortex. 1975; 11(3):230-238.
19. Fahn S Elton RL, The members of the UPDRS Development Committee. The Unified Parkinson-s disease rating scale. In: Fahn S Marsden CD Calne DB Goldstein M, eds Recent Developments in Parkinson-s Disease. Florham Park, NJ: Macmillan Healthcare; 1987; 2: 153-163.
20. Folstein M Folstein S McHugh P. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12(3):189-198.
21. Dubois B Slachevsky A Litvan I Pillon B. The FAB: a frontal assessment battery at bedside. Neurology. 2000; 55(11):1621-1626.
22. Wechsler D. Wechsler Adult Intelligence Scale Manual-R. New York, NY: Grune & Stratton; 1981.
23. Stroop JR. Studies of interference in spatial and verbal reactions. J Exp Psychol. 1935; 18: 643-662.
24. Cummings JL Mega M Gray K, et al The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994; 44(12):2308-2314.
25. Greene JG Smith R Gardiner M Timburg GC. Measuring behavioural disturbance of elderly demented in patients in the community and its effects on relatives: a factor analytic study. Age Ageing. 1982; 11(2):121-126.
26. Alexopoulos GS Abrams RC Young RC Shamoian CA. Cornell scale for depression in dementia. Biol Psychiatry. 1988; 23(3):271-284.
27. Reisberg B Borenstein J Salob SP Ferris SH Franssen E Georgotas A. Behavioral symptoms in Alzheimer-s disease: phenomenology and treatment. J Clin Psychiatr. 1987; 48(suppl 1):9-15.
28. Ott BR Lafleche G Whelihan WM Buongiorno GW Albert MS Fogel BS. Impaired awareness of deficits in Alzheimer-s Disease. Alzheimer Dis Assoc Disord. 1996; 10(2):68-76.
29. Marin RS Biedrzycki RC Firinciogullari S. Reliability and validity of the apathy evaluation scale. Psychiatr Res. 1991; 38(2):143-162.
30. Schultz W Dayan P Montague PR. A neural substrate of prediction and reward. Science. 1997; 275(5306):1593-1599.
31. Rolls ET. The neurophysiological basis of brain-stimulation reward. In: Wauquier A Rolls ET, eds Brain Stimulation Rewards. Amsterdam: North Holland; 1976: 65-87.
32. Robbins TW Everitt BJ. Neurobehavioural mechanisms of reward and motivation. Curr Opin Neurobiol. 1996; 6(2):228-236.
33. Fiorillo CD Tobler PN Schultz W. Discrete coding of reward probability and uncertainty by dopamine neurons. Science. 2003; 299(5614):1898-1902.
34. Ruberg M Agid Y. Dementia in Parkinson-s disease. In: Iversen L Iversen SD Snyder SH, eds Handbook of Psychopharmacology. New York, NY: Plenum Press; 1988: 157-205.
35. Bechara A Damasio AR Damasio H Anderson SW. Insensitivity to future consequences following damage to human prefrontal cortex. Cognition. 1994; 50(1-3):7-15.
36. Rolls ET Hornak J Wade D McGrath J. Emotion-related learning in patients with social and emotional changes associated with frontal lobe damage. J Neurol Neurosurg Psychiatry. 1994; 57(12):1518-1524.
37. Czernecki V Pillon B Houeto JL Pochon JB Levy R Dubois B. Motivation, reward, and Parkinson-s disease: influence of dopatherapy. Neuropsychologia. 2002; 40(13):2257-2267.
38. Pillon B Boller F Levy R Dubois B. Cognitive deficits in Parkinson-s disease. In: Boller F, Grafman J, eds Handbook of Neuropsychology. Amsterdam: Elsevier; 2002. 37 Rolls ET, Sienkiewicz ZJ, Yaxley S,. Hunger modulates the responses to gustatory stimuli of single neurons in the caudolateral orbitofrontal cortex of the macaque monkey. Eur J Neurosci. 1989;1(1):53-60. 38 Jahanshahi M, Jenkins IH, Brown RG, Marsden CD, Passingham RE, Brooks DJ,. Self-initiated versus externally triggered movements. I. An investigation using measurement of regional cerebral blood flow with PET and movement-related potentials in normal and Parkinson-s disease subjects. Brain. 1995;118(pt 4):913-933. 39 Samuel M, Ceballos-Baumann AO, Turjanski N,, et alPallidotomy in Parkinson-s disease increases supplementary motor area and prefrontal activation during performance of volitional movements an H2(15)O PET study. Brain. 1997;120(pt 8):1301-1313. 40 Jenkins IH, Jahanshahi M, Jueptner M, Passingham RE, Brooks DJ,. Self-initiated versus externally triggered movements. II. The effect of movement predictability on regional cerebral blood flow. Brain. 2000;123(pt 6):1216-1228. 41 Moretti R, Torre P, Antonello RM, eds. Basal Ganglia and Thalamus: Their Role in Cognition and Behavior. NewYork: Novascience Editor; 2009.
39. Dujardin K Sockeel P elliaux M DESTEE A Defebvre L. Apathy may herald cognitive decline and dementia in Parkinsons-s Disease. Mov Disord. 2009; 24(16):2391-2397.
40. Hughes TA Ross HF Mindham RH Spokes EG. Mortality in Parkinson-s disease and its association with dementia and depression. Acta Neurol Scand. 2004; 110(2):118-123.
41. Levy ML Cummings JL Fairbanks LA, et al Apathy is not depression. J Neuropsychiatry Clin Neurosci. 1998; 10(3):314-319.